DJ Biogen Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 1.67% to $218.43 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.10% to 51,231.64 and the S&P 500 Index falling 0.47% to 7,765.36.
This was the stock's third consecutive day of losses.
Biogen Inc. closed 5.23% short of its 52-week high of $230.49, which the company achieved on September 28th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.76% to $256.48, Pfizer Inc. $(PFE)$ fell 0.64% to $27.82, and AbbVie Inc. $(ABBV)$ rose 0.39% to $272.42.
Trading volume (1.3 M) eclipsed its 50-day average volume of 951,054.
Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2026.